Hong Kong Exchange records show that on August 26, Executive Director Wang Yuxiao sold 6,500 shares of Remegen (09995) at an average price of HK$82 per share, totaling HK$533,000.

Following the transaction, Wang's direct shareholding decreased to 22.2921 million shares, representing 10.69% of the company's issued shares, according to the latest disclosure filings.